July 2019 Formulary Update
Posted on July 18, 2019
Health New England’s formularies can be accessed on healthnewengland.org using the “Find A Drug” tool at the top of the page.
The online formularies are updated throughout the year as changes are made. We have three formularies, one for each line of business – Commercial, Medicare Advantage and BeHealthy Partnership/Medicaid. Each formulary includes the tier assignment for each drug and any drug-specific medication management requirements, including quantity limitations, step therapy requirements and prior authorization requirements.
Most recently, the following medications have been reviewed for our Commercial and BeHealthy Partnership/Medicaid line of business:
|
Brand Name: |
Aimovig | Generic Name: | Erenumab-AOOE |
|
Brand Name: |
Ajovy | Generic Name: |
Fremanezumab-VFRM |
|
Brand Name: |
Ameluz | Generic Name: |
Aminolevulnic Acid |
| Brand Name: | Dexycu | Generic Name: |
Dexmethasone |
| Brand Name: | Emgality | Generic Name: |
Galcanezumab-GNLM |
|
Brand Name: |
Epicyn | Generic Name: |
Hypochlorous acid |
|
Brand Name: |
Inveltys | Generic Name: |
Loteprednol |
| Brand Name: | Nocdura | Generic Name: |
Desmopressin |
| Brand Name: | Zilretta | Generic Name: |
Triamcinolone |
